Bristol-Myers Squibb Company
Location
New Jersey
Founded
1887-04-10
Website
Risk Signals
10470 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Bristol-Myers Squibb Company
Live alerts from global media, monitored by Business Radar
2024-06-28 (investigate-europe.eu)
Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices
Investigate Europe finds 15 of the world’s biggest drugmakers operate more than 1,300 subsidiaries in low-tax territories. These structures helped them amass €580 billion in profits in the past five years. Meanwhile, patients face life-threatening delays for medicines due to high drug prices.
Read more
2022-01-19 (fiercepharma.com)
Did BMS set up a subsidiary to avoid paying $1.4B in US taxes? The Senate finance chairman is on the case |
Tax avoidance allegations have hovered over major players in the pharmaceutical industry for decades. | Tax avoidance allegations have hovered over major players in the pharmaceutical industry for decades. Some of the biggest names in the business have occasionally faced inquiries or have had to pay up to the Internal Revenue Service. Now, Bristol Myers Squibb is at the center of a U.S. senator's tax probe.
Read more
2020-03-02 (globenewswire.com)
BeiGene Reports Fourth Quarter and Full Year 2019 Financial Results
CAMBRIDGE, Mass. and BEIJING, China, March 02, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical...
Read more